Russian Reports of Agreement to Produce Sputnik V in France Denied

Reading Time: < 1 minute

None of France’s pharmaceutical companies have signed a contract with Russia to produce its Sputnik V COVID-19 vaccine, a spokesman for France’s industry ministry said on Tuesday. The French reaction followed media reports by the head of Russia’s RDIF sovereign wealth fund stating an agreement had been sealed. Earlier, the head of RDIF said his organization had struck deals with production facilities in Italy, Spain, France and Germany to manufacture the Russian vaccine. “We have not identified a site which meets their requirements,” the French spokesperson added.

Source: Euractiv

CET Editor

Recent Posts

CEE mulls ramifications of Trump’s victory on trade, defence, environment

As Donald Trump officially declared his victory in the US election, he received congratulations from…

3 days ago

‘Budapest Declaration’ signed as Orban hosts EU summit

European leaders committed to developing a defence industry base and enhancing EU competitiveness at an…

3 days ago

EU, South Korea expand security, defence links

The EU and the Republic of Korea formalised a comprehensive Security and Defence Partnership in…

4 days ago

PKN Orlen CEE’s top firm on Coface 500 list

Poland is the dominant country in the Central and Eastern Europe (CEE) business landscape, with…

4 days ago

To the victor go the spoils – the big winners and losers of Trump’s second presidency – CET op-ed

Hungarian Prime Minister Viktor Orban, no stranger to political brinkmanship, went all in on Donald…

1 week ago

Moldova pivots to EU in presidential vote

Moldovan President Maia Sandu defeated her pro-Russian rival Alexandr Stoianoglo by around 55% to 45% in the presidential second-round…

1 week ago